Recent News

• 09.02.2025 - IMUNON to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
• 08.28.2025 - IMUNON Successfully Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement
• 08.05.2025 - IMUNON Recaps Highlights from 2025 Second Quarter Financial Results Conference Call
• 08.05.2025 - Imunon Second Quarter 2025 Financial Results
• 08.05.2025 - IMUNON Reports Second Quarter 2025 Financial Results and Provides Business Update

Recent Filings

• 08.28.2025 - 8-K Current report
• 08.28.2025 - EX-99.1 EX-99.1
• 08.13.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.12.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.06.2025 - 4 Statement of changes in beneficial ownership of securities